Form 8-K - Current report:
SEC Accession No. 0002070849-26-000013
Filing Date
2026-03-04
Accepted
2026-03-04 16:07:32
Documents
14
Period of Report
2026-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blln-20260304.htm   iXBRL 8-K 32028
2 EX-99.1 a991blln-earningspressrele.htm EX-99.1 153792
6 bllnlogo.jpg GRAPHIC 7830
  Complete submission text file 0002070849-26-000013.txt   329889

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blln-20260304.xsd EX-101.SCH 1797
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blln-20260304_lab.xml EX-101.LAB 22516
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blln-20260304_pre.xml EX-101.PRE 13053
16 EXTRACTED XBRL INSTANCE DOCUMENT blln-20260304_htm.xml XML 3020
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 650-460-2551
BillionToOne, Inc. (Filer) CIK: 0002070849 (see all company filings)

EIN.: 811082020 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42934 | Film No.: 26721238
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)